Neurocrine Biosciences, Inc. (NBIX) - NASDAQ
  • StockConsultant | Send Message 19 Jul

    Stocks at support with high trade quality $VRX $ANTH $APC $CLVS $ED $KEYW $NBIX $RAI $WTR analysis and charts at
      • StockConsultant | Send Message 28 Jun

        Stocks at support with bullish trade quality $INTU $JWN $MDCO $NBIX $NTRI $ONCE $PAYX $PM $WCN analysis
          • StockConsultant | Send Message 16 Jun

            Stocks at support w/ high trade quality $LGF $AAOI $ELNK $MU $NBIX $PEIX analysis at
              • wilkinson99 | Send Message 31 May

                Premarket Top % Gainers: $CPXX 71%, $CCE 71%, $CLF 14%, $CBYL 13%, $CTRV 12%, $TTM 12%, $ICPT 10%, $WR $CHAU $TNXP $NVCR $NBIX $ABIL $SODA
                  • Stephen Simpson, CFA | Send Message 19 May

                    Uncertainties And Wait Times Not Helping Neurocrine Biosciences $NBIX
                      • Bret Jensen | Send Message 20 Apr

                        Biotech M&A Is About To Pick Up – Some Likely Buyout Targets $MDVN, $NBIX, $PGNX
                          • wilkinson99 | Send Message 31 Mar

                            Requested for $NBIX: Buy signal triggered on close over R 38.41 with 41.81 in focus, Support 35.92,Stop 36.07
                              • Capitalist Bull | Send Message 17 Mar

                                Medical stocks continue weak trend: $ILMN $VRX $ENDP $MNK $DEPO $HZNP $NBIX $INCY $IBB $REGN $BIIB $AMGN
                                  • Colin Macleod | Send Message 4 Mar

                                    Stocks to watch for shorts March 4, 2016 $CTRP $DATA $GILD $LULU $NBIX $TEVA $TXT $ZTS
                                      • Capitalist Bull | Send Message 1 Mar

                                        $SCTY $NBIX $INCY rolling over their respectice 10 & 20DMA's.
                                          Company Description
                                          Neurocrine Biosciences, Inc. operates as a product based biopharmaceutical company, which discovers, develops and intends to commercialize drugs for the treatment of neurological and endocrine related diseases and disorders. The company was founded by Kevin C. Gorman and Wylie W. Vale in January... More
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States